tiprankstipranks

Dennis Matheis Insider Profile

4 Followers
Dennis Matheis, Director at DarioHealth, holds 43.03K shares in DarioHealth (Ticker: DRIO), holds 1.03M shares in Lucid Diagnostics (Ticker: LUCD). Most recently, Dennis Matheis Bought ― shares of DarioHealth on Jul 28, 2026 for an estimated value of $965.00K.
tipranks
Dennis Matheis

Dennis Matheis
DarioHealth (DRIO)
Director

Ranked #71,364 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 5 Profitable Transactions

Average Return

-8.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
75.70%
24.30%
A breakdown of Dennis Matheis's holdings

Insider Roles

Lucid Diagnostics
(LUCD)
Director
DarioHealth
(DRIO)
Director
Roles that Dennis Matheis holds in companies

Most Profitable Insider Trade

Stock:
DarioHealth
(DRIO)
Rating:Informative Buy
Date:Jul 28, 2026 - Today
Return:-3.40%
The most profitable trade made by Dennis Matheis

Dennis Matheis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
DarioHealth
Jul 28, 2026
Director
Informative Buy
965.00K
$311.51K
Lucid Diagnostics
May 21, 2026
Director
Informative Buy
245.00K
$970.40K
List of latest transactions for each holding click on a transaction to see Dennis Matheis's performance on stock

Dennis Matheis insider profile FAQ

What is the percentage of profitable transactions made by Dennis Matheis?
The percentage of profitable transactions made by Dennis Matheis is 0%.
    What is the average return per transaction made by Dennis Matheis?
    The average return per transaction made by Dennis Matheis is -8.90%.
      What stocks does Dennis Matheis hold?
      Dennis Matheis holds: DRIO, LUCD stocks.
        What was Dennis Matheis’s latest transaction?
        Dennis Matheis latest transaction was an Informative Buy of $965.00K.
          What was Dennis Matheis's most profitable transaction?
          Dennis Matheis’s most profitable transaction was an Informative Buy of DRIO stock on July 28, 2026. The return on the trade was -3.40%.
            What is Dennis Matheis's role in DarioHealth?
            Dennis Matheis's role in DarioHealth is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.